RE 20 (Atenolol 50 mg)
Pill imprint RE 20 has been identified as Atenolol 50 mg.
Atenolol is used in the treatment of high blood pressure; anxiety; alcohol withdrawal; migraine prevention; supraventricular tachycardia (and more), and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RE 20 (Atenolol 50 mg)
- 50 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium carbonate
silicon dioxide colloidal
sodium lauryl sulfate
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|57866-3330||Direct Dispensing Inc (repackager)|
Note: Inactive ingredients may vary.
Atenolol is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...